Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00450450 · OUTCOME

Estimated Incidence of Grade III-IV Acute Graft-versus-host Disease (aGVHD)

Donor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other Diseases · Source last updated 2022-04-28

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
Percentage of patients
Interval / dispersion
Not reported
Time frame
Up to 3 months

What was measured

Stage III-IV aGVHD is defined as: Stage 0-3 skin, with Stage 2-3 liver, or Stage 2-3 GI; OR Stage 4 skin, liver or GI involvement.

Analysis population: One patient is inevaluable and is excluded from analysis.

Groups in this outcome

Control BM Arm

Conventional bone marrow transplant (BM)

Experimental G-BM Arm

G-CSF (filgrastim) stimulated bone marrow (G-BM)

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Control BM Arm13
Experimental G-BM Arm13

Reported measurements

Source class 1
Values in Percentage of patients · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Control BM Arm7.69Not reportedNot reportedNot reportedNot reported
Experimental G-BM Arm15.38Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        7.69
      2. group Id
        OG001
        value
        15.38
denoms
  1. counts
    1. group Id
      OG000
      value
      13
    2. group Id
      OG001
      value
      13
    units
    Participants
description
Stage III-IV aGVHD is defined as: Stage 0-3 skin, with Stage 2-3 liver, or Stage 2-3 GI; OR Stage 4 skin, liver or GI involvement.
groups
  1. description
    Conventional bone marrow transplant (BM)
    id
    OG000
    title
    Control BM Arm
  2. description
    G-CSF (filgrastim) stimulated bone marrow (G-BM)
    id
    OG001
    title
    Experimental G-BM Arm
param Type
NUMBER
population Description
One patient is inevaluable and is excluded from analysis.
reporting Status
POSTED
time Frame
Up to 3 months
title
Estimated Incidence of Grade III-IV Acute Graft-versus-host Disease (aGVHD)
type
SECONDARY
unit Of Measure
Percentage of patients

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice